Mercosur Bets On Joint Pricing Negotiations And Procurement For Lower Prices, But Slams Hep C Companies
Countries in South America have negotiated lower prices for the immunosuppressant tacrolimus and have their sights on high-cost oncology treatments. However, they have slammed companies selling new hepatitis C treatments for their inflexibility.